Telomerase activity in mouse myeloid leukemic cells and in cells from normal hematopoietic systems

被引:1
作者
Rithidech, K [1 ]
Gordon, CR
Cronkite, EP
机构
[1] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA
[2] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
关键词
telomerase; mouse; leukemia; radiation; blood; bone marrow;
D O I
10.1006/bcmd.2001.0412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The telomeric repeat amplification protocol (TRAP) assay was used to measure telomerase activity in radiation-induced mouse myeloid leukemic (ML) cells and in several populations of normal cells. A detectable level of telomerase activity was found in normal hematopoietic tissues, i.e., bone marrow (BM) cells, day 9 colony-forming unit spleen (CFU-S) colonies, peripheral blood (PB) lymphocytes, and spleen. The level of telomerase activity in normal BM cells was used as a background level. Nine of the I:! cases of ML had higher levels of activity than that of the normal BM cells and therefore they were scored as ML with positive telomerase. The other three cases were considered as ML with negative telomerase because the levels of the enzyme were equivalent to that of normal BM cells. The data indicate that cellular differentiation may suppress telomerase activity in mouse ML cells. In summary, the results suggest that the CBA/Ca mouse model should be a useful animal system for future studies on the assessment of telomerase activity in both malignant and normal hematopoietic cells. (C) 2001 Academic Press.
引用
收藏
页码:496 / 504
页数:9
相关论文
共 50 条
  • [21] Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARα transgenic mouse model
    Santana, B. A. A.
    Pintao, M. C.
    Lima, R. S. Abreu e
    Scheucher, P. S.
    Santos, G. A. S.
    Garcia, A. B.
    Falcao, R. P.
    Rego, E. M.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (05) : 615 - 620
  • [22] Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells
    Warner, JK
    Wang, JCY
    Takenaka, K
    Doulatov, S
    McKenzie, JL
    Harrington, L
    Dick, JE
    LEUKEMIA, 2005, 19 (10) : 1794 - 1805
  • [23] Human Interleukin 3: Effects on Normal and Leukemic Cells
    Barber, Kathryn E.
    Crosier, Philip S.
    Purdie, Karin J.
    Buchanan, Julie M.
    Cattermole, Jennifer A.
    Watson, James D.
    Gillis, Steven
    GROWTH FACTORS, 1989, 1 (02) : 101 - 114
  • [24] The variety of leukemic stem cells in myeloid malignancy
    Wiseman, D. H.
    Greystoke, B. F.
    Somervaille, T. C. P.
    ONCOGENE, 2014, 33 (24) : 3091 - 3098
  • [25] Mesenchymal stem cells originating from ES cells show high telomerase activity and therapeutic benefits
    Ninagawa, Nana
    Murakami, Rumi
    Isobe, Eri
    Tanaka, Yusuke
    Nakagawa, Hiroki
    Torihashi, Shigeko
    DIFFERENTIATION, 2011, 82 (03) : 153 - 164
  • [26] A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains
    Gutierrez-Barbosa, Hernando
    Medina-Moreno, Sandra
    Perdomo-Celis, Federico
    Davis, Harry
    Coronel-Ruiz, Carolina
    Zapata, Juan C.
    Chua, Joel V.
    MICROORGANISMS, 2023, 11 (06)
  • [27] Suppression of telomerase activity in leukemic cells by mutant forms of Rhodospirillum rubrum L-asparaginase
    Pokrovskaya M.V.
    Zhdanov D.D.
    Eldarov M.A.
    Aleksandrova S.S.
    Veselovsky A.V.
    Pokrovskiy V.S.
    Grishin D.V.
    Gladilina J.A.
    Sokolov N.N.
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2017, 11 (3) : 219 - 233
  • [28] Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL
    Pendino, F
    Hillion, J
    Dudognon, C
    Delaunay, J
    Mourah, S
    Podgorniak, MP
    Lafon, I
    Chomienne, C
    Lanotte, M
    Dombret, H
    Rousselot, P
    Ségal-Bendirdjian, E
    LEUKEMIA, 2006, 20 (04) : 599 - 603
  • [29] The variety of leukemic stem cells in myeloid malignancy
    D H Wiseman
    B F Greystoke
    T C P Somervaille
    Oncogene, 2014, 33 : 3091 - 3098
  • [30] Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL
    F Pendino
    J Hillion
    C Dudognon
    J Delaunay
    S Mourah
    M-P Podgorniak
    I Lafon
    C Chomienne
    M Lanotte
    H Dombret
    P Rousselot
    E Ségal-Bendirdjian
    Leukemia, 2006, 20 : 599 - 603